Dr. Philip Mccarthy Discusses Roswell Park Comprehensive Cancer Center's Clinical Trials For Myeloma

Myeloma Crowd Radio: Dr. Philip McCarthy, Roswell Park Cancer Institute

HealthTree Foundation for Multiple Myeloma

Dr McCarthy on Neutrophil Activity in Multiple Myeloma

mPatient Radio: Dr. Phillip McCarthy, Roswell Park Cancer Institute

HealthTree Foundation for Multiple Myeloma

Why Roswell Park for Multiple Myeloma?

Roswell Park Comprehensive Cancer Center

"Just One Day With Us" with Dr. Philip McCarthy

Roswell Park Comprehensive Cancer Center

MCRT Buffalo 2018: Myeloma Maintenance and Future Therapies, Dr. Philip McCarthy

HealthTree Foundation for Multiple Myeloma

Meet Dr. Philip McCarthy

Roswell Park Comprehensive Cancer Center

What Are Clinical Trials?

Roswell Park Comprehensive Cancer Center

MCRT Buffalo 2018: Myeloma Transplant and Maintenance, Dr. Philip McCarthy

HealthTree Foundation for Multiple Myeloma

Dr. McCarthy on Triplet Therapy for Multiple Myeloma

Targeted Oncology

Clinical Trial Offers Hope For Multiple Myeloma Patients

Toxicities Associated With Lenalidomide for Multiple Myeloma

Targeted Oncology

Clinical Trials for Ovarian Cancer at Roswell Park

Roswell Park Comprehensive Cancer Center

Imaging for Multiple Myeloma

Roswell Park Comprehensive Cancer Center

CAR T-Cell Therapy Clinical Trials at Roswell Park

Roswell Park Comprehensive Cancer Center

Predicting long-term outcomes in myeloma: MRD

VJHemOnc – Video Journal of Hematology & HemOnc

CAR-T in myeloma: what is the potential?

VJHemOnc – Video Journal of Hematology & HemOnc

REVLIMID (Lenalidomide) Maintenance Therapy Approved for Multiple Myeloma Patients

Roswell Park Comprehensive Cancer Center

Philip McCarthy: COSTEM highlights

VJHemOnc – Video Journal of Hematology & HemOnc

Treatment-free intervals: what is best for patients?

VJHemOnc – Video Journal of Hematology & HemOnc